About Our Program

As a research center embedded within Kaiser Permanente’s large and dynamic health care system, our investigators have a unique opportunity to apply scientific expertise to real-world clinical problems, translate findings into practice, and share what we learn with the broader community.

Featured Scientist

Dr. Darios Getahun headshot
Darios Getahun, MD, PhD, MPH
Research Scientist II
Division of Epidemiologic Research
626-564-5658
Darios.T.Getahun@kp.org

Dr. Darios Getahun is a perinatal and pediatric epidemiologist with experience in basic and translational research. His research focuses on exploring and understanding potential etiologic factors for adverse pregnancy outcomes, especially among high-risk pregnancies and in vulnerable pregnant women. His ultimate objective is to further our understanding of the impact of pregnancy complications on short- and long-term maternal and child health and to develop effective and safe preventive strategies ...

News

Kaiser Permanente improves emergency care for chest-pain patients

Emergency physicians at Kaiser Permanente hospitals in Southern California reduced hospital admissions and cardiac stress testing by using new criteria to assess the level of risk patients with chest pain have for subsequent cardiac events. The emergency department assessment was implemented across Kaiser Permanente Southern California and has improved the quality and efficiency of care ...

Kaiser Permanente co-hosts embedded research conference

Organizations like Kaiser Permanente can make continuous improvements in the quality, safety, and value of patient care and at the same time contribute to scientific knowledge nationally and internationally by embedding researchers in their health care systems. This week, leaders in the movement toward learning health care systems will meet in Pasadena, Calif. to create ...

Flu vaccine is safe for hospitalized patients

Hospitalized patients who received the flu vaccine had no increased risk of outpatient visits or hospital readmission within seven days of discharge, according to a Kaiser Permanente study published in Mayo Clinic Proceedings. The study also showed that vaccinating hospital patients did not increase the risk of fever or rates of laboratory evaluations for infection. ...

How low is too low? Study highlights serious risks for intensive blood pressure control

Kaiser Permanente research published today in the American Journal of Preventive Medicine found if patients with hypertension taking prescribed medications experience unusually low blood pressures — systolic blood pressure under 110mmHg — they are twice as likely to experience a fall or faint as patients whose treated blood pressure remains 110mmHg and above. This research ...

5 questions for Dr. Jean Lawrence

We asked these 5 questions of Jean M. Lawrence, ScD, MPH, MSSA, senior research scientist with the Department of Research & Evaluation in Southern California. Why did you choose to devote your career to researching ways women and children can live better, healthier lives? I’ve always been interested in women’s and children’s health and started my ...

Events

Upcoming conference

In September, the Department of Research & Evaluation will host the American College of Epidemiology Annual Meeting, which will address the theme of “Real-World Epidemiologic Evidence in Policy and Practice.”

Details on the conference and registration information will be released in early May. Please check the meeting webpage for updates on key dates and deadlines.

Featured Division

Epidemiologic Research

Our epidemiologists seek answers to important health questions with real-world clinical relevance.

Investigators with the Division of Epidemiologic Research apply rigorous research methods to address important health questions that have the potential to change clinical practice and health care delivery. The division’s research portfolio spans the care continuum, from etiology and prevention to survivorship and quality of life.

Division investigators have expertise in traditional epidemiologic studies, post-marketing safety and effectiveness studies, and outcomes research. Current research areas include cancer, cardiovascular disease, diabetes, infectious disease, molecular epidemiology, orthopedics and bone health, perinatal health, pharmacoepidemiology, and vaccines.